Your prediction
Kao Corp. Stock
Kao Corp. took a tumble today and lost -€1.010 (-5.380%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Kao Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Kao Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kao Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kao Corp. | -5.380% | 2.611% | 1.260% | -54.231% | -48.395% | -48.887% | -65.091% |
| Unicharm Corp. | -5.310% | 3.922% | 1.923% | -12.397% | 9.053% | - | - |
| Pola Orbis Holdings Inc. | -2.070% | 2.899% | 5.970% | -3.401% | 2.158% | -45.802% | -63.959% |
| Kose Corp | 3.770% | 14.583% | 21.324% | 0.610% | 17.857% | -62.712% | -74.615% |
News
Alignment Healthcare Q2 Earnings Call Highlights
Key Points
- Interested in Alignment Healthcare, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Membership rose 31% year over year to 294,100, while revenue
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost


